Navigation Links
Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
Date:11/19/2012

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

http://www.reportlinker.com/p01041706/Active-Pharmaceutical-Ingredients-API-Global-Market-to-2017---Growth-in-Developing-Markets-to-Come-From-Cost-Efficient-Manufacturing-and-Rising-Domestic-Demand.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=IT_Hosting

Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Summary

GBI Research's report, "Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand" provides detailed insight into the global APIs market. The research presents detailed analysis and forecasts of the major economic and market trends affecting the global APIs market. The report contains market forecasts, product type analysis, and drivers and restraints for growth. In addition, it includes therapeutic category analysis and contract manufacturing organizations' (CMO) growth in the region, and their influence on API manufacturing activity towards 2017. Overall, the report presents a comprehensive analysis of the global APIs market, covering all the major parameters. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

The global APIs market was dominated by North America, which generated 35.1% of global API revenues in 2011. The Asia-Pacific region also saw high growth, second behind North America with a revenue share of 29.7% in 2011.

The global APIs market revenues reached $108,613m in 2011. In the product-based segments, the synthetic market dominated the market with 82.7% of global APIs revenues.

However, increasing acceptance and increasing penetration are boosting the biopharmaceuticals drug market in both developed and developing economies.

Scope

- Market revenue data for APIs from 2005 to 2011, forecast forward for six years to 2017.

- API markets in the regions of North America, Asia-Pacific and Europe, along with key countries such as the US, Canada, Japan, China, South Korea, India, Italy, Germany, France, the UK and Spain.

- API industry structure and market trends, such as a shift in manufacturing and growth in biotechnology globally.

- Drivers and restraints for the global APIs market.

- Detailed historical, forecast trend and share analysis of API revenues based on product types (synthetic and biotechnology APIs) at the global, regional and key country levels.

- Detailed historical and forecast trends and share analysis for API revenues based on the customer base (generic and innovative for synthetic APIs, biosimilars and biologics for biotech APIs) at the global, regional and key country levels.

- Analysis of API revenues based on therapeutic categories at a global and regional level.

Reasons to buy

- Develop business strategies with the help with specific insights in the global API market.

- Identify opportunities and challenges in the global API market.

- Invest in the growing segments of the APIs market.

- Increase future revenue and profitability with the help of insights into the future opportunities and critical success factors in the global APIs market.

- Benchmark your operations and strategies against the major players in the global APIs market.

1 Table of Contents

1 Table of Contents 6

1.1 List of Tables 10

1.2 List of Figures 12

2 Introduction 15

3 Global Active Pharmaceutical Ingredients Market 16

3.1 Global API Market Overview 16

3.2 Global API Market Drivers 16

3.2.1 Patent Expiries to Change the Dynamics of the Global API Market 16

3.2.2 Increased Uptake of Biologics Across Different Therapeutic Areas and Government Initiatives for Biomedical Research Set to Boost API Revenues 16

3.2.3 Increased Mergers and Acquisitions to Drive Global Pharmaceutical Industry Growth 16

3.2.4 Increasing Geographical Penetration and Elderly Population to Drive Growth of the Global Pharmaceutical and API Markets 16

3.2.5 Patent Expiries of Major Drugs to Support Pharmaceutical Market Revenue Growth in Underpenetrated Markets 17

3.3 Global API Market Restraints 17

3.3.1 Economic Recession to Restrict Investment in the Pharmaceutical Industry 17

3.3.2 Limited Improvement in Pharmaceutical Manufacturing Capabilities May Reduce Overall Growth Potential 17

3.3.3 Increasing Patent Expiries to Impede Growth of the Global API Market 17

3.3.4 Regulatory Changes to Delay the Launch of New Drugs 18

3.4 Global API Market Revenue Analysis and Forecast to 2017 19

3.4.1 Global API Market Revenue Share by Product Type 21

3.4.2 Global Synthetic Market Revenue Analysis and Forecast to 2017 22

3.4.3 Global Synthetic Market Revenue Share Analysis by Customer Base 26

3.4.4 Global Synthetic Market Revenue Analysis and Forecast to 2017 27

3.5 Global Biotech Market Analysis 29

3.5.1 Global Biotech Market Revenue Analysis and Forecast to 2017 29

3.6 Global Biotech Market Revenue Analysis by Customer Base 34

3.6.1 Global Biotech Market Revenue Share Analysis by Customer Base 34

3.6.2 Global Biotech Market Revenue Analysis and Forecast to 2017 35

3.7 Global Contract Manufacturing Organizations 37

3.7.1 Global CMO Outsourcing Process 38

3.7.2 Global CMO Market Drivers 39

3.7.3 Global CMO Market Outsourcing Benefits 40

3.7.4 Global CMO Market Revenues and Forecast to 2017 41

4 North America Active Pharmaceutical Ingredients Market 43

4.1 North America API Market Overview 43

4.2 North America API Market Drivers 43

4.2.1 Continuous Growth in the Pharmaceutical Industry to Sustain API Market Growth in North America 43

4.2.2 Generic Sector Supports the Growth of the North American API Market 43

4.2.3 Increasing Focus on Biological Drugs to Support API Market Revenue Growth 43

4.3 North American API Market Restraints 44

4.3.1 Recent Economic Slowdown has Restricted Pharmaceutical Industry Growth 44

4.3.2 High Cost of New Drug Development Hampers Innovation 44

4.3.3 Patent Expiries of Blockbuster Molecules to Contain API Market Growth in North America 44

4.4 North America API Market Revenue Analysis and Forecast to 2017 45

4.5 North America API Market Revenue Share Analysis by Product Type 47

4.6 North America Synthetic Market Analysis 48

4.6.1 North America Synthetic Market Revenue Analysis and Forecast to 2017 48

4.6.2 North America Synthetic Market Revenue Share Analysis by Customer Base 53

4.6.3 North America Synthetic Market Revenue Analysis by Customer Base and Forecast to 2017 54

4.7 North America Biotech Market Analysis 56

4.7.1 North America Biotech Market Revenue Analysis and Forecast to 2017 56

4.7.2 North America Biotech Market Revenue Share Analysis by Customer Base 61

4.7.3 North America Biotech Market Revenue Analysis by Customer Base and Forecast to 2017 62

4.8 North America API Market Revenue Share Analysis by Therapeutic Applications 64

4.9 The US Active Pharmaceutical Ingredients Market 65

4.9.1 The US API Market Overview 65

4.9.2 The US API Market Revenue by Product Type and Forecast to 2017 66

4.9.3 The US API Market Revenue Share Analysis by Product Type and Forecast to 2017 68

4.9.4 The US API Market by Customer Base 69

4.10 Canada Active Pharmaceutical Ingredients Market 75

4.10.1 Canada API Market Overview 75

4.10.2 Canada API Market Revenue Analysis by Product Type and Forecast to 2017 75

4.10.3 Canada API Market Revenue Share Analysis by Product Types and Forecast to 2017 77

4.10.4 Canada API Market by Customer Base 78

5 Asia-Pacific Active Pharmaceutical Ingredients Market 84

5.1 Asia-Pacific API Market Overview 84

5.2 Asia-Pacific APIs Market Drivers 85

5.2.1 Pharmaceutical Manufacturing Capabilities in Developing Countries such as China and India to Attract API Manufacture 85

5.2.2 Domestic Market Growth of Developing Countries in Asia-Pacific to Drive Global Pharmaceutical Industry Growth 85

5.2.3 Increasing Focus on Biotech API Drugs in Asia-Pacific will Contribute to Major Asia-Pacific API Market Growth 85

5.2.4 Improving Regulatory Framework in China and India is Increasing Penetration for Branded Drugs 85

5.2.5 Patent Expiries of Blockbuster Drugs to Boost Market Revenues in Asia-Pacific Markets 85

5.3 Asia-Pacific API Market Restraints 86

5.3.1 Increasing Incidence of Patent Expiries to Hamper Growth for Branded API Market 86

5.3.2 Highly Fragmented Market to Restrict Revenue Growth for the Asia-Pacific API Market 86

5.3.3 Limited Improvement in Pharmaceutical Manufacturing Capabilities may Hamper Overall Growth Potential 86

5.3.4 Currency Fluctuations to Hamper Value Growth of Pharmaceutical Market in Asia-Pacific Region 86

5.4 Asia-Pacific API Market Revenue and Forecasts to 2017 87

5.5 Asia-Pacific Revenue Share Analysis by Product Type 89

5.6 Asia-Pacific Synthetic Market 90

5.6.1 Asia-Pacific Synthetic Market Revenues and Forecast to 2017 90

5.6.2 Asia-Pacific Synthetic Market Revenue Share Analysis by Consumer Base 95

5.6.3 Asia-Pacific Synthetic Market Revenues by Customer Base and Forecast to 2017 96

5.7 Asia-Pacific Biotech Market 98

5.7.1 Asia-Pacific Biotech Market Revenues and Forecasts to 2017 98

5.7.2 Asia-Pacific Biotech Market Revenue Share Analysis by Customer Base 104

5.7.3 Asia-Pacific Biotech Market Revenue by Customer Base and Forecast to 2017 105

5.8 Asia-Pacific API Market Share Analysis by Therapeutic Applications 107

5.9 Japan Active Pharmaceutical Ingredients Market 108

5.9.1 Japan API Market Overview 108

5.9.2 Japan API Market Revenues and Forecasts to 2017 108

5.9.3 Japan API Market Revenue Share Analysis by Product Type 110

5.9.4 Japan API Market by Customer Base 111

5.10 China Active Pharmaceutical Ingredients Market 117

5.10.1 China API Market Overview 117

5.10.2 China API Market Revenues by Product Type and Forecasts to 2017 118

5.10.3 China API Market Revenue Share Analysis by Product Types 120

5.10.4 China API Market by Customer Base 121

5.11 South Korea Active Pharmaceutical Ingredients Market 127

5.11.1 South Korea API Market Overview 127

5.11.2 South Korea APIs Market Revenue and Forecasts to 2017 128

5.11.3 South Korea API Market Revenue Share Analysis by Product Type 130

5.11.4 South Korea API Market by Customer Base 131

5.12 India Active Pharmaceutical Ingredients Market 137

5.12.1 India API Market Overview 137

5.12.2 India API Market Revenue and Forecasts to 2017 138

5.12.3 India API Market Revenue Share Analysis by Product Types 140

5.12.4 India API Market by Customer Base 141

6 Europe Active Pharmaceutical Ingredients Market 147

6.1 Europe API Market Overview 147

6.2 Europe API Market Drivers 147

6.2.1 Increased CMO Opportunities Expected to Improve the Production of Generics and Drive API Revenue Growth in Europe 147

6.2.2 Overall Growth in the Pharmaceutical Industry and Increasing Elderly Population to Drive the Growth for the European API Market 147

6.2.3 Biopharmaceutical Therapies to Support API Market Growth in Europe 147

6.2.4 European Regulatory Framework to Facilitate Development of Biosimilars 147

6.2.5 Differences in VAT rates on Pharma Products to Increase Parallel Trade in Europe 147

6.3 Europe API Market Restraints 148

6.3.1 Increased Consumption of Generics to Limit the Premium Earned from Branded Products 148

6.3.2 Increasing Patent Expiries to Hamper the Growth of the European API Market 148

6.3.3 Price Cuts to Restrict Revenue Growth for the European API Market 149

6.4 Europe API Market Revenue Analysis and Forecast to 2017 151

6.5 Europe API Market Revenue Share Analysis by Product Type 153

6.6 Europe Synthetic Market Analysis 154

6.6.1 Europe Synthetic Market Revenue Analysis and Forecast to 2017 154

6.6.2 European Synthetic Market Revenue Share Analysis by Customer Base 159

6.6.3 Europe Synthetic Market Revenue by Customer Base and Forecast to 2017 160

6.7 Europe Biotech Market Analysis 162

6.7.1 Europe Biotech Market Revenue Analysis and Forecast to 2017 162

6.7.2 Europe Biotech Market Revenue Share Analysis by Customer Base 167

6.7.3 Europe Biotech Market Revenues by Customer Base and Forecast to 2017 168

6.8 Europe API Market Revenue Share Analysis by Therapeutic Applications 170

6.9 Germany Active Pharmaceutical Ingredients Market 172

6.9.1 Germany API Market Overview 172

6.9.2 Germany API Market Revenue Analysis by Product Type and Forecast to 2017 172

6.9.3 Germany API Market Revenue Share Analysis by Product Type and Forecast to 2017 174

6.9.4 Germany API Market by Customer Base 175

6.10 France Active Pharmaceutical Ingredients Market 181

6.10.1 France API Market Overview 181

6.10.2 France API Market Revenue Analysis by Product Type and Forecast to 2017 181

6.10.3 France API Revenue Share Analysis by Product Type and Forecast to 2017 183

6.10.4 France API Market by Customer Base 184

6.11 Italy Active Pharmaceutical Ingredients Market 190

6.11.1 Italy API Market Overview 190

6.11.2 Italy API Market Revenue Analysis by Product Type and Forecast to 2017 190

6.11.3 Italy API Market Revenue Share Analysis by Product Type and Forecast to 2017 192

6.11.4 Italy API Market by Customer Base 193

6.12 The UK Active Pharmaceutical Ingredients Market 199

6.12.1 The UK API Market Overview 199

6.12.2 The UK API Market Revenue Analysis by Product Type and Forecast to 2017 199

6.12.3 The UK API Market Revenue Share Analysis by Product Types and Forecast to 2017 201

6.12.4 The UK API Market by Customer Base 202

6.13 Spain Active Pharmaceutical Ingredients Market 208

6.13.1 Spain API Market Overview 208

6.13.2 Spain API Market Revenue Analysis by Product Type and Forecast to 2017 208

6.13.3 Spain API Market Revenue Share Analysis by Product Types and Forecast to 2017 210

6.13.4 Spain API Market by Customer Base 211

7 Appendix 217

7.1 Abbreviations 217

7.2 Bibliography 218

7.3 Market Definitions 219

7.4 Methodology 219

7.4.1 Coverage 219

7.4.2 Secondary Research 220

7.4.3 Primary Research 220

7.4.4 Expert Panel Validation 220

7.5 Contact Us 221

7.6 Disclaimer 221

1.1 List of Tables

Table 1: API Market, Global, Total Revenue Analysis, $m, 2005–2017 20

Table 2: API Market, Global, Revenue Share by Product Types, %, 2011 21

Table 3: Synthetic Market, Global, Revenue Analysis, $m, 2005–2017 23

Table 4: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2011 24

Table 5: Synthetic Market, Global, Revenue Share Analysis by Region, %, 2005–2017 25

Table 6: Synthetic Market, Global, Revenue Share by Customer Base, %, 2011 26

Table 7: Synthetic Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 28

Table 8: Biotech Market, Global, Revenue Analysis, $m, 2005–2017 30

Table 9: Biotech Market, Global, Revenue Share by Region, %, 2011 31

Table 10: Biotech Market, Global, Revenue Share Analysis by Region, %, 2005–2017 33

Table 11: Biotech Market, Global, Revenue Share Analysis by Customer Base, %, 2011 34

Table 12: Biotech Market, Global, Revenue Analysis by Customer Base, $m, 2005–2017 36

Table 13: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost, $/Operator/Year, 2011 39

Table 14: CMO Market, Global, Market Revenues, $m, 2005–2017 42

Table 15: API Market, North America, Major Drugs to Lose Patent Protection, 2012–2016 44

Table 16: API Market, North America, Revenue Analysis by Product Type, $m, 2005–2017 46

Table 17: API Market, North America, Revenue Share by Product Type, %, 2005–2017 47

Table 18: Synthetic Market, North America, Revenue Analysis, $m, 2005–2017 49

Table 19: Synthetic Market, North America, Revenue Share Analysis by Countries, $m and %, 2011 50

Table 20: Synthetic Market, North America, Revenue Share Trend, %, 2005–2017 52

Table 21: Synthetic Market, North America, Revenue Share by Customer Base, (%), 2011 53

Table 22: Synthetic Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017 55

Table 23: Biotech Market, North America, Revenue Analysis, $m, 2005–2017 57

Table 24: Biotech Market, North America, Revenue Share by Countries, $m and %, 2011 58

Table 25: Biotech Market, North America, Revenue Share Trend, %, 2005–2017 60

Table 26: Biotech Market, North America, Revenue Share Analysis by Customer Base, %, 2011 61

Table 27: Biotech Market, North America, Revenue Analysis by Customer Base, $m, 2005–2017 63

Table 28: API Market, North America, Revenue Split by Therapeutic Applications, %, 2011–2017 65

Table 29: API Market, The US, Revenue Analysis by Product Type, $m, 2005–2017 67

Table 30: API Market, The US, Revenue Share Analysis by Product Type, %, 2005–2017 68

Table 31: Synthetic Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 70

Table 32: Synthetic Market, The US, Revenue Share by Customer Base, %, 2005–2017 71

Table 33: Biotech Market, The US, Revenue Analysis by Customer Base, $m, 2005–2017 73

Table 34: Biotech Market, The US, Revenue Share by Customer Base, %, 2005–2017 74

Table 35: API Market, Canada, Revenue Analysis by Product Type, $m, 2005–2017 76

Table 36: API Market, Canada, Revenue Share by Product Type, %, 2005–2017 77

Table 37: Synthetic Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 79

Table 38: Synthetic Market, Canada, Revenue Share by Customer Base, %, 2005–2017 80

Table 39: Biotech Market, Canada, Revenue Analysis by Customer Base, $m, 2005–2017 82

Table 40: Biotech Market, Canada, Revenue Share by Customer Base, %, 2005–2017 83

Table 41: API Market, Asia-Pacific, Market Revenues, $m, 2005–2017 88

Table 42: API Market, Asia-Pacific, Revenue Share by Product Types, $m and %, 2011 89

Table 43: Synthetic Market, Asia-Pacific, Market Revenues, $m, 2005–2017 91

Table 44: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 92

Table 45: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries, $m, 2005–2017 95

Table 46: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base, %, 2011 95

Table 47: Synthetic Market, Asia-Pacific, Market Revenues by Product Types, $m, 2005–2017 97

Table 48: Biotech Market, Asia-Pacific, Market Revenues, $m, 2005–2017 99

Table 49: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m and %, 2011 100

Table 50: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries, $m, 2005, 2011 and 2017 103

Table 51: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base, $m and %, 2011 104

Table 52: Biotech Market, Asia-Pacific, Market Revenues by Product Type, $m, 2005–2017 106

Table 53: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications, %, 2011–2017 107

Table 54: API Market, Japan, Market Revenues by Product Types, $m, 2005–2017 109

Table 55: API Market, Japan, Revenue Share Analysis by Product Types, %, 2005–2017 110

Table 56: Synthetic Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 112

Table 57: Synthetic Market, Japan, Revenue Share by Customer Base, %, 2005–2017 113

Table 58: Biotech Market, Japan, Market Revenues by Customer Base, $m, 2005–2017 115

Table 59: Biotech Market, Japan, Revenue Share Analysis by Customer Base, %, 2005–2017 116

Table 60: API Market, China, Market Revenues by Product Type, $m, 2005–2017 119

Table 61: API Market, China, Revenue Share Analysis by Product Type, %, 2005–2017 120

Table 62: Synthetic Market, China, Market Revenues by Customer Base, $m, 2005–2017 122

Table 63: Synthetic Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017 123

Table 64: Biotech Market, China, Market Revenues by Customer Base, $m, 2005–2017 125

Table 65: Biotech Market, China, Revenue Share Analysis by Customer Base, %, 2005–2017 126

Table 66: API Market, South Korea, Market Revenues by Product Types, $m, 2005–2017 129

Table 67: API Market, South Korea, Revenue Share Analysis by Product Types, %, 2005–2017 130

Table 68: Synthetic Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017 132

Table 69: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017 133

Table 70: Biotech Market, South Korea, Market Revenues by Customer Base, $m, 2005–2017 135

Table 71: Biotech Market, South Korea, Revenue Share Analysis by Customer Base, %, 2005–2017 136

Table 72: API Market, India, Market Revenues by Product Types, $m, 2005–2017 139

Table 73: API Market, India, Revenue Share Analysis by Product Types, %, 2005–2017 140

Table 74: Synthetic Market, India, Market Revenues by Customer Base, $m, 2005–2017 142

Table 75: Synthetic Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 143

Table 76: Biotech Market, India, Market Revenues by Customer Base, $m, 2005–2017 145

Table 77: Biotech Market, India, Revenue Share Analysis by Customer Base, %, 2005–2017 146

Table 78: Pharmaceutical Market, Leading Five European Countries, Pricing and Reimbursement Mechanism, 2011 149

Table 79: API Market, Europe, Total Revenue Analysis, $m, 2005–2017 152

Table 80: API Market, Europe, Revenue Share by Product Types, %, 2011 153

Table 81: Synthetic Market, Europe, Revenue Analysis, $m, 2005–2017 155

Table 82: Synthetic Market, Europe, Revenue Share Analysis by Countries, %, 2011 156

Table 83: Synthetic Market, Europe, Revenue Share Trend, %, 2005–2017 158

Table 84: Synthetic Market, Europe, Revenue Share by Customer Base, %, 2011 159

Table 85: Synthetic Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 161

Table 86: Biotech Market, Europe, Revenue Analysis, $m, 2005–2017 163

Table 87: Biotech Market, Europe, Revenue Share by Countries, %, 2011 164

Table 88: Biotech Market, Europe, Revenue Share Trend, %, 2005–2017 166

Table 89: Biotech Market, Europe, Revenue Share Analysis by Customer Base, %, 2011 167

Table 90: Biotech Market, Europe, Revenue Analysis by Customer Base, $m, 2005–2017 169

Table 91: API Market, Europe, Revenue Split by Therapeutic Applications, %, 2011–2017 171

Table 92: API Market, Germany, Revenue Analysis by Product Types, $m, 2005–2017 173

Table 93: API Market, Germany, Revenue Share by Product Type, %, 2005–2017 174

Table 94: Synthetic Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 176

Table 95: Synthetic Market, Germany, Revenue Share by Customer Base, %, 2005–2017 177

Table 96: Biotech Market, Germany, Revenue Analysis by Customer Base, $m, 2005–2017 179

Table 97: Biotech Market, Germany, Revenue Share by Customer Base, %, 2005–2017 180

Table 98: API Market, France, Revenue Analysis by Product Types, $m, 2005–2017 182

Table 99: API Market, France, Revenue Share by Product Type, %, 2005–2017 183

Table 100:Synthetic Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 185

Table 101:Synthetic Market, France, Revenue Share by Customer Base, %, 2005–2017 186

Table 102:Biotech Market, France, Revenue Analysis by Customer Base, $m, 2005–2017 188

Table 103:Biotech Market, France, Revenue Share by Customer Base, %, 2005–2017 189

Table 104:API Market, Italy, Revenue Analysis by Product Types, $m, 2005–2017 191

Table 105:API Market, Italy, Revenue Share by Product Type, %, 2005–2017 192

Table 106:Synthetic Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 194

Table 107:Synthetic Market, Italy, Revenue Share by Customer Base, %, 2005–2017 195

Table 108:Biotech Market, Italy, Revenue Analysis by Customer Base, $m, 2005–2017 197

Table 109:Biotech Market, Italy, Revenue Share by Customer Base, %, 2005–2017 198

Table 110:API Market, The UK, Revenue Analysis by Product Types, $m, 2005–2017 200

Table 111:API Market, The UK, Revenue Share by Product Type, %, 2005–2017 201

Table 112:Synthetic Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 203

Table 113:Synthetic Market, The UK, Revenue Share by Customer Base, %, 2005–2017 204

Table 114:Biotech Market, The UK, Revenue Analysis by Customer Base, $m, 2005–2017 206

Table 115:Biotech Market, The UK, Revenue Share by Customer Base, %, 2005–2017 207

Table 116:API Market, Spain, Revenue Analysis by Product Types, $m, 2005–2017 209

Table 117:API Market, Spain, Revenue Share by Product Type, %, 2005–2017 210

Table 118:Synthetic Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 212

Table 119:Synthetic Market, Spain, Revenue Share by Customer Base, %, 2005–2017 213

Table 120:Biotech Market, Spain, Revenue Analysis by Customer Base, $m, 2005–2017 215

Table 121:Biotech Market, Spain, Revenue Share by Customer Base, %, 2005–2017 216

1.2 List of Figures

Figure 1: API Market, Global, Total Revenue Analysis ($m), 2005–2017 19

Figure 2: API Market, Global, Revenue Share by Product Type (%), 2011 21

Figure 3: Synthetic Market, Global, Revenue Analysis ($m), 2005–2017 22

Figure 4: Synthetic Market, Global, Revenue Share Analysis (%), 2011 24

Figure 5: Synthetic Market, Global, Revenue Share Analysis by Region (%), 2005–2017 25

Figure 6: Synthetic Market, Global, Revenue Share by Customer Base (%), 2011 26

Figure 7: Synthetic Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 27

Figure 8: Biotech Market, Global, Revenue Analysis ($m), 2005–2017 29

Figure 9: Biotech Market, Global, Revenue Share by Region (%), 2011 31

Figure 10: Biotech Market, Global, Revenue Share Analysis by Region (%), 2005–2017 32

Figure 11: Biotech Market, Global, Revenue Share Analysis by Customer Base (%), 2011 34

Figure 12: Biotech Market, Global, Revenue Analysis by Customer Base ($m), 2005–2017 35

Figure 13: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project 38

Figure 14: CMO Market, Asia-Pacific, Fine Chemical Industry Labor Cost ($/Operator/Year), 2011 39

Figure 15: CMO Market Key Benefits of Outsourcing to CMOs 40

Figure 16: CMO Market, Global, Market Revenue ($m), 2005-2017 41

Figure 17: API Market, North America, Revenue Analysis by Product Type ($m), 2005–2017 45

Figure 18: API Market, North America, Revenue Share by Product Type (%), 2005–2017 47

Figure 19: Synthetic Market, North America, Revenue Analysis ($m), 2005–2017 48

Figure 20: Synthetic Market, North America, Revenue Share Analysis by Countries (%), 2011 50

Figure 21: Synthetic Market, North America, Performance and Potential Analysis Grid (%), 2005–2017 51

Figure 22: Synthetic Market, North America, Revenue Share Trend Analysis by Countries (%), 2005–2017 52

Figure 23: Synthetic API, North America, Revenue Share by Customer Base (%), 2011 53

Figure 24: Synthetic Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017 54

Figure 25: Biotech Market, North America, Revenue Analysis ($m and %), 2005–2017 56

Figure 26: Biotech Market, North America, Revenue Share by Countries (%), 2011 58

Figure 27: Biotech Market, North America, Performance and Potential Analysis Grid (%), 2005–2017 59

Figure 28: Biotech Market, North America, Revenue Share Trend (%), 2005–2017 60

Figure 29: Biotech Market, North America, Revenue Share Analysis by Customer Base (%), 2011 61

Figure 30: Biotech Market, North America, Revenue Analysis by Customer Base ($m), 2005–2017 62

Figure 31: API Market, North America, Revenue Split by Therapeutic Applications (%), 2011–2017 64

Figure 32: API Market, The US, Revenue Analysis by Product Type ($m), 2005–2017 66

Figure 33: API Market, The US, Revenue Share Analysis by Product Type (%), 2005–2017 68

Figure 34: Synthetic Market, The US, Revenue Analysis by Customer Base ($m), 2005–2017 69

Figure 35: Synthetic Market, The US, Revenue Share by Customer Base (%), 2005–2017 71

Figure 36: Biotech API, The US, Revenue Analysis by Customer Base ($m), 2005–2017 72

Figure 37: Biotech Market, The US, Revenue Share by Customer Base (%), 2005–2017 74

Figure 38: API Market, Canada, Revenue Analysis by Product Type ($m), 2005–2017 75

Figure 39: API Market, Canada, Revenue Share by Product Type (%), 2005–2017 77

Figure 40: Synthetic Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 78

Figure 41: Synthetic Market, Canada, Revenue Share by Customer Base (%), 2005–2017 80

Figure 42: Biotech Market, Canada, Revenue Analysis by Customer Base ($m), 2005–2017 81

Figure 43: Biotech Market, Canada, Revenue Share by Customer Base (%), 2005–2017 83

Figure 44: API Market, Asia-Pacific, Market Revenues ($m), 2005–2017 87

Figure 45: API Market, Asia-Pacific, Revenue Share by Product Type (%), 2011 89

Figure 46: Synthetic Market, Asia-Pacific, Market Revenues ($m), 2005–2017 90

Figure 47: Synthetic Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 92

Figure 48: Synthetic Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017 93

Figure 49: Synthetic Market, Asia-Pacific, Revenue Analysis by Countries (%), 2005–2017 94

Figure 50: Synthetic Market, Asia-Pacific, Revenue Share by Customer Base (%), 2011 95

Figure 51: Synthetic Market, Asia-Pacific, Revenue Trend Analysis by Product Type ($m), 2005–2017 96

Figure 52: Biotech Market, Asia-Pacific, Market Revenues ($m and %), 2005–2017 98

Figure 53: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries (%), 2011 100

Figure 54: Biotech Market, Asia-Pacific, Performance and Potential Analysis Grid (%), 2005–2017 101

Figure 55: Biotech Market, Asia-Pacific, Revenue Share Analysis by Countries ($m), 2005–2017 102

Figure 56: Biotech Market, Asia-Pacific, Revenue Share Analysis by Customer Base (%), 2011 104

Figure 57: Biotech Market, Asia-Pacific, Market Revenues by Product Type ($m), 2005–2017 105

Figure 58: API Market, Asia-Pacific, Revenue Share Analysis by Therapeutic Applications (%), 2011–2017 107

Figure 59: API Market, Japan, Market Revenues by Product Type ($m), 2005–2017 108

Figure 60: API Market, Japan, Revenue Share Analysis by Product Types (%), 2005–2017 110

Figure 61: Synthetic Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 111

Figure 62: Synthetic Market, Japan, Revenue Share by Customer Base (%), 2005–2017 113

Figure 63: Biotech Market, Japan, Market Revenues by Customer Base ($m), 2005–2017 114

Figure 64: Biotech Market, Japan, Revenue Share Analysis by Customer Base (%), 2005–2017 116

Figure 65: API Market, China, Market Revenues by Product Type ($m), 2005–2017 118

Figure 66: API Market, China, Revenue Share Analysis by Product Type (%), 2005–2017 120

Figure 67: Synthetic Market, China, Market Revenues by Customer Base ($m), 2005–2017 121

Figure 68: Synthetic Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017 123

Figure 69: Biotech Market, China, Market Revenues by Customer Base ($m), 2005–2017 124

Figure 70: Biotech Market, China, Revenue Share Analysis by Customer Base (%), 2005–2017 126

Figure 71: API Market, South Korea, Market Revenues by Product Type ($m), 2005–2017 128

Figure 72: API Market, South Korea, Revenue Share Analysis by Product Types (%), 2005–2017 130

Figure 73: Synthetic Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017 131

Figure 74: Synthetic Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017 133

Figure 75: Biotech Market, South Korea, Market Revenues by Customer Base ($m), 2005–2017 134

Figure 76: Biotech Market, South Korea, Revenue Share Analysis by Customer Base (%), 2005–2017 136

Figure 77: API Market, India, Market Revenues by Product Types ($m), 2005–2017 138

Figure 78: API Market, India, Revenue Share Analysis by Product Types (%), 2005–2017 140

Figure 79: Synthetic Market, India, Market Revenues by Customer Base ($m), 2005–2017 141

Figure 80: Synthetic Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017 143

Figure 81: Biotech Market, India, Market Revenues by Customer Base ($m), 2005–2017 144

Figure 82: Biotech Market, India, Revenue Share Analysis by Customer Base (%), 2005–2017 146

Figure 83: API Market, Europe, Total Revenue Analysis ($m), 2005–2017 151

Figure 84: API Market, Europe, Revenue Share by Product Types (%), 2011 153

Figure 85: Synthetic Market, Europe, Revenue Analysis ($m), 2005–2017 154

Figure 86: Synthetic Market, Europe, Revenue Share Analysis by Countries (%), 2011 156

Figure 87: Synthetic Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017 157

Figure 88: Synthetic Market, Europe, Revenue Share Trend Analysis by Countries (%), 2005–2017 158

Figure 89: Synthetic Market, Europe, Revenue Share by Customer Base, (%), 2011 159

Figure 90: Synthetic Market, Europe, Revenue Trend by Product Types ($m), 2005–2017 160

Figure 91: Biotech Market, Europe, Revenue Analysis ($m and %), 2005–2017 162

Figure 92: Biotech Market, Europe, Revenue Share by Countries (%), 2011 164

Figure 93: Biotech Market, Europe, Performance and Potential Analysis Grid (%), 2005–2017 165

Figure 94: Biotech Market, Europe, Revenue Share Trend (%), 2005–2017 166

Figure 95: Biotech Market, Europe, Revenue Share Analysis by Customer Base (%), 2011 167

Figure 96: Biotech Market, Europe, Revenue Analysis by Customer Base ($m), 2005–2017 168

Figure 97: API Market, Europe, Revenue Split by Therapeutic Applications (%), 2011–2017 170

Figure 98: API Market, Germany, Revenue Analysis by Product Types ($m), 2005–2017 172

Figure 99: API Market, Germany, Revenue Share by Product Type (%), 2005–2017 174

Figure 100: Synthetic Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017 175

Figure 101: Synthetic Market, Germany, Revenue Share by Customer Base (%), 2005–2017 177

Figure 102: Biotech Market, Germany, Revenue Analysis by Customer Base ($m), 2005–2017 178

Figure 103: Biotech Market, Germany, Revenue Share by Customer Base (%), 2005–2017 180

Figure 104: API Market, France, Revenue Analysis by Product Types ($m), 2005–2017 181

Figure 105: API Market, France, Revenue Share by Product Type (%), 2005–2017 183

Figure 106: Synthetic Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 184

Figure 107: Synthetic Market, France, Revenue Share by Customer Base (%), 2005–2017 186

Figure 108: Biotech Market, France, Revenue Analysis by Customer Base ($m), 2005–2017 187

Figure 109: Biotech Market, France, Revenue Share by Customer Base (%), 2005–2017 189

Figure 110: API Market, Italy, Revenue Analysis by Product Types ($m), 2005–2017 190

Figure 111: API Market, Italy, Revenue Share by Product Type (%), 2005–2017 192

Figure 112: Synthetic Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 193

Figure 113: Synthetic Market, Italy, Revenue Share by Customer Base (%), 2005–2017 195

Figure 114: Biotech Market, Italy, Revenue Analysis by Customer Base ($m), 2005–2017 196

Figure 115: Biotech Market, Italy, Revenue Share by Customer Base (%), 2005–2017 198

Figure 116: API Market, The UK, Revenue Analysis by Product Types ($m), 2005–2017 199

Figure 117: API Market, The UK, Revenue Share by Product Type (%), 2005–2017 201

Figure 118: Synthetic Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017 202

Figure 119: Synthetic Market, The UK, Revenue Share by Customer Base (%), 2005–2017 204

Figure 120: Biotech Market, The UK, Revenue Analysis by Customer Base ($m), 2005–2017 205

Figure 121: Biotech Market, The UK, Revenue Share by Customer Base (%), 2005–2017 207

Figure 122: API Market, Spain, Revenue Analysis by Product Types ($m), 2005–2017 208

Figure 123: API Market, Spain, Revenue Share by Product Type (%), 2005–2017 210

Figure 124: Synthetic Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 211

Figure 125: Synthetic Market, Spain, Revenue Share by Customer Base (%), 2005–2017 213

Figure 126: Biotech Market, Spain, Revenue Analysis by Customer Base ($m), 2005–2017 214

Figure 127: Biotech Market, Spain, Revenue Share by Customer Base (%), 2005–2017 216

To order this report:

IT_Hosting Industry: Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved


Related medicine technology :

1. Warm Weather Means Active Children May Be Prone To More Injuries
2. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
3. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
4. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
5. AUA Foundation Launches Campaign to Address Stigma of Overactive Bladder
6. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
7. United Seating & Mobility Completes Acquisition of Active American Mobility
8. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
9. New Molecular Assay Allows Healthcare Facilities to Simplify Active Surveillance Testing for Deadly Superbug
10. EJK Duisburg Becomes One of the Most Active SynCardia Certified Centers in Europe
11. How to Create Dynamic Interactive Social Learning Spaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  SI-BONE, Inc., a medical device company ... ("iFuse"), a minimally invasive surgical (MIS) device indicated for fusion for ... Services, Inc. (NGS), the Medicare Administrative Contractor (MAC) covering the states ... Maine , Massachusetts , ... New York , Rhode Island , ...
(Date:2/12/2016)... and SEOUL, South Korea ... Menarini and Macrogen, Inc. today announced they will ... innovative procedures for precision medicine in cancer. The ... Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput Next ... certified under the Clinical Laboratory Improvement Amendments (CLIA) ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis ... completed a $47.1 million Series D preferred ... Asset Management, Hillhouse Capital Group and venBio ... Venture Investments, AJU IB Investment, and Epidarex ... used to further advance clinical trials in ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... Miami Dental Specialists is excited ... their Miami dental office. Beginning in January, Miami Dental Specialists will offer the non-metal ... are the first office to be chosen by the dental implant manufacturer, Straumann, to ...
(Date:2/12/2016)... ... 12, 2016 , ... Nearly every health website and vision ... articles generally list between five and 15 foods that should be consumed regularly ... of these lists and believes that nutritious eye healthy foods are extremely important, ...
(Date:2/12/2016)... Colo. (PRWEB) , ... February 12, 2016 , ... A ... the past 35 years. A president has access to health and wellness resources most ... the free world, no single individual has a schedule as frenetic as the U.S. ...
(Date:2/12/2016)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... the real facts surrounding all those Bible stories. For generations families have gathered to ... Yisrayl says there is more to these than just mere “stories”. , The ...
(Date:2/12/2016)... ... ... Dignity Health named Dr. Scott Bingham the Facility Medical Director of the ... licensed under Dignity Health Arizona General Hospital , which opened last year in ... our new freestanding emergency room delivers the highest quality care to Mesa and the ...
Breaking Medicine News(10 mins):